Acroscell Offers Cardiac Ion Channel Screen Panels to Detect and Analyze Effects of Candidate Drugs
Acroscell announced the release of its cardiac ion channel screen panels to detect and analyze the effected of candidate drugs. New York, USA – December 3, 2021 – Acroscell, the mature division of Creative Bioarray, is dedicated to developing top-quality products and cutting-edge technologies for the academia, pharmaceutical, and biotechnology industries. As a service company […]




